{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SoC%29&page=16", "query": { "intervention": "Standard of Care (SoC)", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 1103, "total_pages": 111, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SoC%29&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+Care+%28SoC%29&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-13T23:33:02.926Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06416150", "title": "Reducing Urban Cervical Cancer Disparities", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Cancer", "Papilloma Viral Infection" ], "interventions": [ { "name": "Stage 1 SOC", "type": "BEHAVIORAL" }, { "name": "Stage 1 HERS", "type": "BEHAVIORAL" }, { "name": "Stage 2 HERS", "type": "BEHAVIORAL" }, { "name": "Stage 2 HERS+HC", "type": "BEHAVIORAL" }, { "name": "Stage 3 SOC", "type": "BEHAVIORAL" }, { "name": "Stage 3 HERS", "type": "BEHAVIORAL" }, { "name": "Stage 3 HERS+HC", "type": "BEHAVIORAL" }, { "name": "Stage 4 HERS", "type": "BEHAVIORAL" }, { "name": "Stage 4 HERS+HC", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Fox Chase Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "FEMALE", "summary": "18 Years to 90 Years · Female only" }, "enrollment_count": 546, "start_date": "2024-08-28", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2024-10-26", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 3, "location_summary": "New Brunswick, New Jersey • Philadelphia, Pennsylvania", "locations": [ { "city": "New Brunswick", "state": "New Jersey" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06416150" }, { "nct_id": "NCT04385368", "title": "Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "Durvalumab + SoC chemotherapy", "type": "DRUG" }, { "name": "Placebo + SoC chemotherapy", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 89, "start_date": "2020-07-17", "completion_date": "2023-08-31", "has_results": true, "last_update_posted_date": "2024-08-30", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Long Beach, California • Santa Rosa, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "West Hollywood", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04385368" }, { "nct_id": "NCT04368247", "title": "Skin Fluorescent Imaging (SFI) System in Patients With Nevi", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nevus", "Dysplasia; Epithelial" ], "interventions": [ { "name": "Skin Fluorescent Imaging", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Orlucent, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2020-08-10", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 4, "location_summary": "Fremont, California • Northridge, California • Vallejo, California + 1 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Vallejo", "state": "California" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04368247" }, { "nct_id": "NCT07702578", "title": "A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "AML", "MDS" ], "interventions": [ { "name": "TSC-101", "type": "DRUG" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "TScan Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 310, "start_date": "2026-06-18", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 26, "location_summary": "Gilbert, Arizona • Scottsdale, Arizona • Duarte, California + 21 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07702578" }, { "nct_id": "NCT07227649", "title": "NAC-REPAIR for Post-surgical Pain", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carpal Tunnel Surgery", "Trigger Finger Disorder", "De Quervain Syndrome", "Guyon's Canal", "Dupuytren Contracture", "Morton Neuroma", "Tarsal Tunnel Syndrome", "Plantar Fasciopathy", "Peroneal Nerve Entrapment" ], "interventions": [ { "name": "NAC", "type": "DRUG" }, { "name": "NAC 0mg/day (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 80, "start_date": "2026-10-15", "completion_date": "2027-07-15", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07227649" }, { "nct_id": "NCT05352919", "title": "A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Lupus Erythematosus (SLE)" ], "interventions": [ { "name": "Litifilimab", "type": "DRUG" }, { "name": "Litifilimab-matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 864, "start_date": "2022-06-10", "completion_date": "2032-05-03", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 38, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Huntington Beach, California + 34 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05352919" }, { "nct_id": "NCT04872777", "title": "Mobile Health Delivered Lifestyle Intervention Program in Patients With NASH", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non-alcoholic Steatohepatitis" ], "interventions": [ { "name": "Noom Healthy Weight", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2021-06-08", "completion_date": "2022-02-10", "has_results": false, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 1, "location_summary": "Marietta, Pennsylvania", "locations": [ { "city": "Marietta", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04872777" }, { "nct_id": "NCT00945607", "title": "Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "GRT (Guided Relaxation Training)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Trinitas Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "18 Years to 75 Years · Female only" }, "enrollment_count": 40, "start_date": "2009-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2011-07-25", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 1, "location_summary": "Elizabeth, New Jersey", "locations": [ { "city": "Elizabeth", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00945607" }, { "nct_id": "NCT04612244", "title": "The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Paroxysmal Atrial Fibrillation" ], "interventions": [ { "name": "FARAPULSE Pulsed Field Ablation System", "type": "DEVICE" }, { "name": "RadioFrequency and Cryoballoon Ablation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Scientific Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 706, "start_date": "2021-03-01", "completion_date": "2023-05-15", "has_results": true, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04612244" }, { "nct_id": "NCT04134728", "title": "Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "GSK3196165 (Otilimab)", "type": "BIOLOGICAL" }, { "name": "Sarilumab", "type": "BIOLOGICAL" }, { "name": "Placebo to GSK3196165/ Sarilumab", "type": "DRUG" }, { "name": "csDMARDs", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2019-10-31", "completion_date": "2022-02-01", "has_results": true, "last_update_posted_date": "2023-07-17", "last_synced_at": "2026-10-13T23:33:02.926Z", "location_count": 46, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Sun City, Arizona + 36 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04134728" } ] }